Cetirizine Hydrochloride (Allergy)
NDC 57483-190, Cetirizine Hydrochloride, tablet, from INNOVUS PHARMACEUTICALS, INC..
- Product NDC
- 57483-190
- Status
- Listed
- Labeler
- INNOVUS PHARMACEUTICALS, INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA090760
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57483-190 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57483-190-14 | 57483019014 | 365 TABLET in 1 BOTTLE (57483-190-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 57483-190 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57483-190 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57483-190. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.